The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Current understanding of Alzheimer’s disease diagnosis and treatment
Open accessAbstract
Alzheimer’s disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. This neurodegenerative disease process is characterized classically by two hallmark pathologies: β-amyloid plaque deposition and neurofibrillary tangles of hyperphosphorylated tau. Diagnosis is based upon clinical presentation fulfilling several criteria as well as fluid and imaging biomarkers. Treatment is currently targeted toward symptomatic therapy, although trials are underway that aim to reduce the production and overall burden of pathology within the brain. Here, we discuss recent advances in our understanding of the clinical evaluation and treatment of Alzheimer’s disease, with updates regarding clinical trials still in progress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, both PET imaging and CSF analysis exhibit similar accuracy, and suggest that the optimum test for the diagnosis will depend upon patient/provider preference, cost and availability of facilities [37].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [37]
In the citing paper
“Current therapeutics to ameliorate and control the cognitive and behavioral symptoms by targeting the NMDA receptor prevent Ca2+ induced excitotoxicity [2, 9–11], and memantine was approved for this purpose in 2003.”
From Current therapeutics for Alzheimer’s disease and clinical trials (2024) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzen, E. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0655 · Cited by 8,467
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796
Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,643
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Cited by
Sorted by citations
Items 601–700 of 1,000
The Neurosteroid Hormone Vitamin D: Modern Prospects
Lebedev, A. S., Shevlyakov, A. D., Ilyin, N. P., Galstyan, D. S., Golushko, N. I., & Kalueff, A. V. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024060024 · Cited by 5
Sinibaldi, A., Chiavaioli, F. E., Occhicone, A., Danz, N., Munzert, P., Baldini, F., Giannetti, A. E., & Michelotti, F. (2025) · Advanced Sensor Research · doi:10.1002/adsr.202400164 · Cited by 6
Enrichment of phosphorylated Tau 181 levels in tear fluid-derived extracellular vesicles
Schmeetz, J., van de Sande, N., Ramakers, I. H. G. B., Verhey, F. R. J., Benedikter, B. J., Nuijts, R. M. M. A., Webers, C. A. B., & Gijs, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107134 · Cited by 5
Jangra, J., Mahindru, I., Kumar, A., Gupta, H. K., Ramesh, V. K., & Kumar, R. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2636501 · Cited by 5
Bukhari, S. N. A., & Yogesh, R. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220405232333 · Cited by 5
Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease
Pérez‐Silanes, S., Martišová, E., Moreno, E., Solas, M., Plano, D., Sanmartín, C., & Ramírez, M. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020799 · Cited by 5
Browne, K., England, A., Young, R., Moore, N., Kjelle, E., Owen, A., & McEntee, M. F. (2024) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2024.01.003 · Cited by 6
Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease
Compton, H., Smith, M. L., Bull, C. J., Korologou‐Linden, R., Ben‐Shlomo, Y., Bell, J. A., Williams, D. M., & Anderson, E. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-54569-w · Cited by 7
Mercerón‐Martínez, D., Ricardo, L. A., Pina, A. B., Rojo, N. O., Seco, A. E., Hurtado, Y. V., Días, B. E., Fernández, I., García-Pupo, L., Sablón-Carrazana, M., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148848 · Cited by 5
Wang, C., Yu, W., Xu, T., Zeng, H., Cuello, A. M. G., Fernández‐Villalba, E., Xu, F., Chu, F., Herrero, M. T., & Tao, M. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.72 · Cited by 5
Autoencoder imputation of missing heterogeneous data for Alzheimer's disease classification
Haridas, N. T., Sánchez‐Bornot, J. M., McClean, P. L., Wong‐Lin, K., & Initiative, A. D. N. (2024) · Healthcare Technology Letters · doi:10.1049/htl2.12091 · Cited by 5
Liu, J., Yang, J.-B., Wang, Y., Hu, X.-R., Wang, Y.-D., Nie, L., Wei, F., Yu, J., Yao, L., Xu, B., et al. (2024) · Pharmaceutical Biology · doi:10.1080/13880209.2024.2415660 · Cited by 5
Yakemow, G., Kolesar, T. A., Wright, N., Beheshti, I., Choi, E. H., Ryner, L. N., Chaulk, S. J., Patel, R., & Ko, J. H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1470727 · Cited by 5
Climacosa, F. M. M., Anlacan, V. M. M., Gordovez, F. J. A., Reyes, J. C. B., Tabios, I. K. B., Manalo, R. V. M., Cruz, J. M. C., Asis, J. L. B., Razal, R. B., Abaca, M. J. M., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078660 · Cited by 5
Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases
Guo, F., Qin, X., Mao, J., Xu, Y. C., & Xie, J. (2024) · Molecules · doi:10.3390/molecules29235700 · Cited by 4
Schwab, K., Robinson, L., Annschuetz, A., Dreesen, E., Magbagbeolu, M., Melis, V., Theuring, F., Harrington, C. R., Wischik, C. M., & Riedel, G. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111172 · Cited by 4
Johnson, E. A., Nowar, R., Viola, K. L., Huang, W., Zhou, S., Bicca, M. A., Zhu, W., Kranz, D. L., Klein, W. L., & Silverman, R. B. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402117122 · Cited by 5
Optical signature of retinal Tau fibrillation
Salajková, Z., Barolo, L., Baiocco, P., Ruzicka, B., Mura, F., Lorenzo, F. D., Boffi, A., Ricco, V., Ruocco, G., & Leonetti, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-92565-w · Cited by 5
Chaar, D., Li, Z., Shang, L., Ratliff, S. M., Mosley, T. H., Kardia, S. L. R., Zhao, W., Zhou, X., & Smith, J. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062443 · Cited by 7
Mai, Y., Huang, F., Mi, H., Cao, Z., Li, Y., Zhou, K., Liu, J., Xie, G., & Liao, W. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00756 · Cited by 5
Luisetto, M., Nili-Ahmadabadi, B., Rafa, A. Y., Sahu, R. K., Cabianca, L., Mashori, G. R., & Khan, F. A. (2019) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001023 · Cited by 5
Dymek, A., & Mroczek, T. (2021) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2021-0016 · Cited by 5
ArtontheBrain: Results of a Pilot Project Among Long-Term Care Residents
Howard, E., Retalic, T., Rogan, J., Murphy, K. J., Swaminathan, S., & Altschuler, A. (2021) · Research in Gerontological Nursing · doi:10.3928/19404921-20210825-03 · Cited by 5
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Jervies, J. L., King, S. P., & Suphioglu, C. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000475 · Cited by 5
Soudy, R., Kimura, R., Fu, W., Patel, A., & Jhamandas, J. H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267164 · Cited by 5
Differential Diagnosis Findings Between Alzheimer’s Disease and Major Depressive Disorder: A Review
Durães, R. S. S., Yokomizo, J. E., Saffi, F., Rocca, C. C. D. A., & Serafim, A. D. P. (2022) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2022.21133 · Cited by 6
Iyer, R. R., Renteria, C. A., Yang, L., Sorrells, J. E., Park, J., Sun, L., Yu, Z., Huang, Y., Marjanović, M., Mirica, L. M., et al. (2022) · Journal of Biophotonics · doi:10.1002/jbio.202200105 · Cited by 6
A Slip Between the Brain and the Lip: Working Memory and Cognitive-Communication Disorders
Savarimuthu, A., & Ponniah, R. J. (2023) · Journal of Psycholinguistic Research · doi:10.1007/s10936-023-09946-3 · Cited by 5
Behavioural, genomics and proteomic approach to examine Alzheimer's disease in zebrafish
Siddiqui, A., Abidin, S. A. Z., Shah, Z. A., Othman, I., & Kumari, Y. (2023) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2023.109636 · Cited by 5
Zhao, K.-P., Wang, X., Shao, M.-Q., He, C.-Y., & Yuan, F. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231184988 · Cited by 5
Ayurvedic herbs–derived cognitive enhancers for the management of Alzheimer's disease (AD)
Muralidhara, M., & Rajini, P. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00002-8 · Cited by 4
Summary of the Current Status of DNA Vaccination for Alzheimer Disease
Vicidomini, C., Borbone, N., Roviello, V., Roviello, G. N., & Oliviero, G. (2023) · Vaccines · doi:10.3390/vaccines11111706 · Cited by 5
Khalifa, M. K. A., Abdel-Sattar, S. A., Amin, O. M., Kohaf, N. A., Zaky, H. S., El-Fattah, M. A. A., Mohammed, K. H. A., Badawi, N. M., Mansoor, I., & Eassa, H. A. (2023) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-023-00494-8 · Cited by 8
Махаева, Г. Ф., Рудакова, Е. В., Ковалева, Н. В., Boltneva, N. P., Lushchekina, S. V., Proshin, A. N., Serkov, I. V., & Бачурин, С. О. (2023) · Russian Chemical Bulletin · doi:10.1007/s11172-023-4080-y · Cited by 5
Liposomes as carrier for drug delivery in Alzheimer's disease
Patel, R. J., Patel, A. A., Trivedi, N., Pandya, V., Alexander, A., Patel, V. F., Prajapati, B. G., & Parejiya, P. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00008-x · Cited by 7
A joint autoencoder and classifier deep neural network for AD and MCI classification
Ganotra, R., Gupta, S., & Dora, S. (2024) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.23054 · Cited by 5
Phyto-nanotechnology: A novel beneficial strategy for Alzheimer's disease therapy
Ganguly, S. C., Sangram, S., Paul, S., & Kundu, M. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105868 · Cited by 5
Parviz, G., Güler, E., Hazar-Yavuz, A. N., Yekeler, H. B., Tatar, E., Kocar, F., Şermet, S., Asghar, A., Wang, X., Ikram, F., et al. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106887 · Cited by 5
Sasidharakurup, H., Nalarajan, N., Nair, M., Mubarak, S., Koranath, A., & Diwakar, S. (2020) · Procedia Computer Science · doi:10.1016/j.procs.2020.04.171 · Cited by 5
Dai, J. M., Nishi, A., Tran, N., Yamamoto, Y., Dewey, G., Ugai, T., & Ogino, S. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1952073 · Cited by 6
A comprehensive study on early detection of Alzheimer disease using convolutional neural network
Oommen, D. K., & Arunnehru, J. (2022) · AIP conference proceedings · doi:10.1063/5.0071058 · Cited by 5
Palley, B. F., Artur, J. C., de Arruda, M. N., de Souza, G. F., Graves, D. A., Bovolato, A. L. D. C., Deffune, E., Schelp, A. O., Gonçalves, E. S., & de Moraes, M. L. (2022) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/ac584f · Cited by 5
Zebrafish: A Potential Preclinical Model for Neurological Research in Modern Biology
Saleem, S., & Kannan, R. R. (2022) · Springer eBooks · doi:10.1007/978-981-16-5217-2_14 · Cited by 5
The promise and challenges of extracellular vesicles in the diagnosis of neurodegenerative diseases
Hagey, D. W., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00014-x · Cited by 5
Rani, V., Verma, R., Kumar, K., & Chawla, R. (2023) · Journal of Biosciences · doi:10.1007/s12038-023-00343-5 · Cited by 5
Beşli, N., Johnson, B. S., Cakmak, R. K., & Kılıç, Ü. (2023) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2023.23029 · Cited by 9
Nanoscale rearrangement of APP organization as a therapeutic target for Alzheimer’s disease
Kedia, S., & Nair, D. K. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110143 · Cited by 5
Herpes zoster and Alzheimer’s disease
Lai, S., Kuo, Y., & Liao, K. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01311-6 · Cited by 5
Dang, W., Hao, T., Li, N., Zhang, H., Li, Z., Yu, H., Wen, Y., Zheng, D., & Liu, L. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1488528 · Cited by 4
Neuroprotective mechanism of ribisin A on H2O2-induced PC12 cell injury model
Zhang, X., Bao, M., Zhang, J., Zhu, L., Wang, D., Liu, X., Xu, L., Luan, L., Liu, Y., & Liu, Y. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102322 · Cited by 4
Valero-Rojas, J., Ramírez-Sánchez, C. A., Pacheco-Paternina, L., Valenzuela-Hormazábal, P., Saldívar‐González, F. I., Santana, P., González, J., Gutiérrez-Bunster, T., Valdés-Jiménez, A., & Ramírez, D. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01481 · Cited by 4
Oljačić, S., Popovic-Nikolic, M., Filipić, B., Gagić, Ž., & Nikolic, K. M. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266337668241025061804 · Cited by 5
Dementia in People With Multiple Sclerosis: A Systematic Review and Meta‐Analysis
Mirmosayyeb, O., Firouzabadi, D. D., Oraee, S., Alinejadfard, M., Panah, M. Y., Vaheb, S., Ghoshouni, H., & Shaygannejad, V. (2025) · Brain and Behavior · doi:10.1002/brb3.70588 · Cited by 4
Reddy, M. M., Jayanandan, A., Reddy, E. K., Anwar, S., & Sadasivan, C. (2025) · Organic & Biomolecular Chemistry · doi:10.1039/d5ob00785b · Cited by 4
Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential
Yan, Y., Maisenbacher, M., Huang, C., & Fan, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107849 · Cited by 6
Lin, J., & Huang, W. (2025) · Journal of Engineering and Applied Science · doi:10.1186/s44147-025-00674-0 · Cited by 4
Metal–Organic Frameworks as Interfacial Platforms for Early Diagnosis of Alzheimer’s Disease
Thokal, G., Garg, M., Bathinapatla, A., Farale, H., & Kanchi, S. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c04804 · Cited by 5
Yan, M.-Q., Tang, Y., Zhang, S., Yu, L., & Xu, C. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111711 · Cited by 4
Ariyath, A., Mputhia, Z., Dougherty, C., Rahuman, B. K., Fernando, W. M. A. D. B., Brown, B. M., Gardener, S. L., Rainey‐Smith, S. R., Martins, R. N., & Bharadwaj, P. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71191 · Cited by 4
Liu, X., Yu, J., Luo, Y.-Y., & Dong, H. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14111 · Cited by 5
Lu, X. (2022) · AIP conference proceedings · doi:10.1063/5.0095072 · Cited by 4
Babylon, L., Meißner, J., & Eckert, G. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210029 · Cited by 4
Chandy, T. (2023) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-0025 · Cited by 4
Fadilah, F., Kezia, I., & Erlina, L. (2023) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres23.1715_12.2.204 · Cited by 5
Gupte, P., Dhingra, K., & Saloni (2024) · Journal of Knowledge Learning and Science Technology · doi:10.60087/jklst.v3.n4.p11 · Cited by 23
Development of Alzheimer's disease and the organic changes involved in the process
Turrini, S. M., Rosa, R. A. C., & Rosa, B. C. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594802427083 · Cited by 4
EEGNET for the Classification of Mild Cognitive Impairment
Saroja, P., Nalini, N. J., & Mahesh, G. (2024) · Lecture notes in networks and systems · doi:10.1007/978-981-97-4895-2_29 · Cited by 4
Jin, J., Lü, L., Hua, K., Fang, L., Li, X., & Li, W. (2024) · Current Alzheimer Research · doi:10.2174/0115672050341904241111082935 · Cited by 5
Farina, F. R., Pragulbickaitė, G., Bennett, M., Judd, C., Walsh, K. S., Mitchell, S., O’Connell, R. G., & Whelan, R. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14652 · Cited by 4
Goins, H., HekmatiAthar, S., Byfield, G. E., Samuel, R. E., & Anwar, M. M. (2020) · IEEE International Conference on Information Reuse and Integration (IRI) · doi:10.1109/iri49571.2020.00061 · Cited by 4
Alonso-Hernández, J. B., Barragán-Pulido, M. L., Gil-Bordón, J. M., Ferrer, M. A., & Travieso, C. M. (2021) · Applied Sciences · doi:10.3390/app11073228 · Cited by 4
Deciphering the focal role of endostatin in Alzheimer’s disease
Kaur, D., Behl, T., Chigurupati, S., Sehgal, A., Singh, S., Sharma, N., Badavath, V. N., Vargas-De-La-Cruz, C. B., Bhatia, S., Al‐Harrasi, A., et al. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16567-7 · Cited by 4
Zhang, W., Dun, S., Ping, Y., Wang, Q., Tana, S., Tana, A., Qin, S., Bao, X., Qimuge, A., Baiyin, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21676-5 · Cited by 4
Pagar, R. R., & Suryawanshi, M. V. (2022) · INDIAN DRUGS · doi:10.53879/id.59.11.12690 · Cited by 4
Ontology-Driven Knowledge Sharing in Alzheimer’s Disease Research
Lazarova, S., Petrova‐Antonova, D., & Kunchev, T. (2023) · Information · doi:10.3390/info14030188 · Cited by 4
Combinatorial therapy in Alzheimer's disease
Giri, M. A., Kendre, P. N., Bhalke, R. D., Pande, V. V., Autade, K. A., & Sumbe, R. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00026-1 · Cited by 4
Acupuncture therapy for Alzheimer's disease
Wang, L., Xu, J., Zhan, Y., & Pei, J. (2020) · Medicine · doi:10.1097/md.0000000000020244 · Cited by 4
Mondal, M., Solomon, S., Sun, J., Sampathkumar, N. K., Carre, I., Côtel, M.-C., Mehta, P. R., Rajendran, L., Vernon, A. C., Fang, F., et al. (2023) · medRxiv · doi:10.1101/2023.11.10.23298358 · Cited by 4
Li, A., Zhu, Q., Li, Y., Yang, L., Chen, Z., Zhou, X., & Xia, Y. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03988-4 · Cited by 3
Kee, K. V., Lim, Y. S., Tan, E. X., & Yam, W. K. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00011 · Cited by 3
Sun, X., Hu, X., Wei, J., & An, H. (2025) · Biological Research · doi:10.1186/s40659-025-00598-2 · Cited by 3
Zou, J., Liu, L., Chai, F., Shan, Q., & Wang, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05084-0 · Cited by 3
Jastrzębski, M. K., Wójcik, P., Mudgal, A., Woźniak, S., Targowska‐Duda, K. M., Wronikowska‐Denysiuk, O., Michalak, A., Jeleniewicz, W., Karcz, T. P., Raczek, J., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70232 · Cited by 3
Bhansali, P. R., Sonkusare, S. M., Savale, S. S., Wijayasinghe, Y. S., Liao, Y., Sloan, D. C., Chaturbhuj, G. U., & Muntean, B. S. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1642190 · Cited by 3
Zhou, M., Tang, S., Zhang, Y., Fu, G., Yu, W., Wang, S., Cheng, S., & Zhenyan, S. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157738 · Cited by 4
Nitric oxide signaling in Alzheimer's disease: A double-edged sword
Wasim, R. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178986 · Cited by 3
Dexamethasone: Therapeutic Applications, Targets and Translation
Hirday, R., Tam, G. H., O’Neill, A. A., Davis, M. S., & Schloss, R. S. (2022) · Nano LIFE · doi:10.1142/s1793984422300035 · Cited by 4
Axenhus, M., Doeswijk, T., Nilsson, P., Matton, A., Winblad, B. G., Tjernberg, L. O., & Schedin‐Weiss, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073622 · Cited by 3
Associations of tau, Aβ, and brain volume of the Papez circuit with cognition in Alzheimer’s disease
Feng, Y., Laraib, A., Lin, X., Li, Q., Zhan, J., & Li, X. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01827-7 · Cited by 3
Hypergraph attention-based feature extraction method for the classification of brain diseases
Li, W., Jie, B., Wu, Z., & Zhou, J. (2024) · International Conference on Computer Vision, Image and Deep Learning (CVIDL) · doi:10.1109/cvidl62147.2024.10603882 · Cited by 3
Virus-like Particles-based Vaccine to Combat Neurodegenerative Diseases
Lim, L. W. C., Jy, L., Chen, C. H., Voon, K., Koh, R. Y., & Chye, S. M. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010331763241002122854 · Cited by 3
Cerebral ischemic injury impairs autophagy and exacerbates cognitive impairment in APP/PS1 mice
Ning, Z., Zhong, X., Wang, Y., Hu, D., Tang, X., & Deng, M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113581 · Cited by 3
Akçeşme, B., Islam, N., Lekic, D., Ćutuk, R., & Basovic, N. (2024) · Neurogenetics · doi:10.1007/s10048-024-00786-4 · Cited by 3
Xiong, L., Li, Q., Zhou, X., Xiao, J., Yang, X., Xu, H., & Guo, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241312970 · Cited by 3
Klotho protein in Alzheimer's disease: Diet leading to immortality?
Walczak, K., Kołodziejczyk, W., Pszczołowska, M., Kozłowska, M., Beszłej, J. A., & Leszek, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251350125 · Cited by 3
Ghosson, A., Soufan, F., Kaddoura, H., Fares, E., & Uwishema, O. (2025) · Health Science Reports · doi:10.1002/hsr2.70975 · Cited by 4
Huang, Y., Li, Z., Liu, F., Li, B., Mao, C., Dong, L., Chu, S., Jin, W., Wang, J., & Gao, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360331 · Cited by 3
Gai, Y., Dai, X., Qian, M., Lin, G., Pan, P., Dai, T., Luo, Y., & Su, L. (2025) · Cognitive Neurodynamics · doi:10.1007/s11571-025-10326-x · Cited by 4
Voice and Speech Disorders in Alzheimer’s Disease: A State-of-the-Art Review
Mayo‐Yáñez, M., & Cabo‐Varela, I. (2020) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2003072 · Cited by 3
Aurooj, A., & Mahmood, Z. (2021) · Journal of Religion and Health · doi:10.1007/s10943-021-01335-1 · Cited by 3
Metadata
- Authors
- Weller, J., & Budson, A.
- Affiliations
- Boston University (US)
- Corresponding author
- Weller, Jason
- Venue
- F1000Research
- Publisher
- F1000 Research Ltd
- Published
- 2018-07-31
- Volume
- 7
- Pages
- 1161
- ISSN
- 2046-1402 (ISSN-L)
- PMC
- PMC6073093
- OpenAlex
- W2885706121
- Cited by
- 1,083
- References
- 53
- Citations by year
- 2026: 67 · 2025: 155 · 2024: 147 · 2023: 176 · 2022: 221 · 2021: 194 · 2020: 92 · 2019: 29 · 2018: 2
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- F1000Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Aging (P30AG013846)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- Alzheimer's disease, dementia, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, biomarkers, diagnosis, symptomatic treatment, disease-modifying therapy, clinical trials, neurodegeneration
- MeSH terms
- Alzheimer Disease, Humans, Nerve Net, Amyloid beta-Peptides, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
